bioAffinity Technologies, Inc. Increase (Decrease) in Interest Payable, Net
bioAffinity Technologies, Inc. (BIAF) reported Increase (Decrease) in Interest Payable, Net of $440.49 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2024-04-01
- bioAffinity Technologies, Inc. increase (decrease) in interest payable, net for the quarter ending 2022-12-31 was -$25.17K, a 115.99% decline year-over-year.
- bioAffinity Technologies, Inc. increase (decrease) in interest payable, net for the quarter ending 2022-09-30 was $128.09K.
- bioAffinity Technologies, Inc. increase (decrease) in interest payable, net for the quarter ending 2022-06-30 was $168.27K.
- bioAffinity Technologies, Inc. increase (decrease) in interest payable, net for the quarter ending 2022-03-31 was $169.30K.
- bioAffinity Technologies, Inc. increase (decrease) in interest payable, net for fiscal 2022 was $440.49K, a 15.46% decline from fiscal 2021.
- bioAffinity Technologies, Inc. increase (decrease) in interest payable, net for fiscal 2021 was $521.05K.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$25.17K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $102.92K derived: sum of 2 quarters · filed 2024-04-01 | $271.19K derived: sum of 3 quarters · filed 2024-04-01 | $440.49K 10-K · filed 2024-04-01 |
| 2022-09-30 | $128.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $296.35K derived: sum of 2 quarters · filed 2023-11-14 | $465.65K 10-Q · filed 2023-11-14 | $623.04K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $168.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $337.57K 10-Q · filed 2023-08-14 | $494.95K derived: sum of 3 quarters · filed 2023-08-14 | |
| 2022-03-31 | $169.30K 10-Q · filed 2023-05-15 | $326.69K derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $157.39K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $521.05K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $363.66K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |